Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer

Clinical trial NCT00052949 · COMPLETED

Trial details

NCT number: NCT00052949
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Small Cell Lung Cancer

Start date: 2003-05-01
Primary completion: 2007-10-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.